Well here are the stocks I plan to follow for this week and for January 2007. Let me know your feelings on any of these. I think these all have potential to be nice winners shortly, or within the next few months.
Here we go...
AAGH, NEOL, FFHL, AMGI, NFLD, FLWE, TBYH, SRCO, PLTT, CORT, HOGC, PNS, TPWR, PFSW, BCYR, NBIX, JAV, and DOVP
Good luck all...
Posted by stocktrader22 on :
Oops I can't forget my favorite for this week and next year
MSMAW
Posted by a surfer on :
One I have followed for a long time is KLGE.
News to come out early in 2007 about new genesis line. Found bottom at .05 and is on the rise. Needs volume. Could easily go back to $1.00 within 3 to 6 months.
Posted by a surfer on :
FFHL news. Fri. after hours AP Fuwei Films IPO Raises $35.7 Million Friday December 22, 4:30 pm ET Fuwei Films Initial Public Offering Sells 4.3 Million Shares, Raises $35.7 Million in Proceeds
NEW YORK (AP) -- Fuwei Films Co. Ltd., a maker of specialty plastic film used in a variety of industries, said its initial public offering raised $35.7 million. The Chinese company said it sold 4.3 million shares at $8.28 per share.
Fuwei Films plans to use the proceeds to invest in research and expand its sales and marketing operations.
Maxim Group LLC served as the sole book runner on the offering and WR Hambrecht and Chardan Capital Markets acted as co-managers.
Shares of Fuwei Films rose $2.26, or 22 percent, to $12.51 in trading on the Nasdaq.
Posted by a surfer on :
Item 2.05. Costs associated with exit or disposal activities On December 21, 2006, NeoPharm Inc. (the "Company") completed an organizational realignment which resulted in a workforce reduction of fourteen (14) positions, or approximately 20% of the workforce. The Company estimates that the costs associated with termination benefits from this workforce reduction will be approximately $300,000 and will yield 2007 cost savings to the Company of approximately $1.5 million as compared to 2006.
This workforce reduction follows the Company's report that its lead drug product candidate, cintredekin besudotox, did not achieve the statistical superiority endpoint established for its pivotal Phase III PRECISE trial. The Company is now focused on evaluating what potential regulatory and commercial strategies may be available for cintredekin besudotox, as well as furthering the clinical development of its LEP-ETU, LE-SN38 and LE-DT drug product candidates which are now entering Phase 3, Phase 2 and Pre-IND stages of development, respectively.
Posted by a surfer on :
NFLD
In the spotlight Wednesday were shares of smallcap biotech Northfield Laboratories Inc.. The Evanston, Ill., company reported poor early stage study results for PolyHeme, a blood substitute product intended for use in trauma treatment.
Northfield shares plummeted $6.57, or 57.5 percent, to close at $4.85 Wednesday. Volume neared 16.2 million shares, or 21.5 times normal trading, as investors fled the stock.
Shares continued south Thursday, losing another 15 percent, and closed flat Friday at $4.12, down a total of 64 percent since the study's release.
ST22 I like this for a bounce play this week.
what are your thoughts??
Posted by a surfer on :
JAV looks like a contender to me too!
Posted by stocktrader22 on :
quote:Originally posted by a surfer: JAV looks like a contender to me too!
yup...this is a hot one to hold for 6 months for a double. I think they have 3 drugs in Phase III in their pipeline right now.
Posted by stocktrader22 on :
quote:Originally posted by a surfer: NFLD
In the spotlight Wednesday were shares of smallcap biotech Northfield Laboratories Inc.. The Evanston, Ill., company reported poor early stage study results for PolyHeme, a blood substitute product intended for use in trauma treatment.
Northfield shares plummeted $6.57, or 57.5 percent, to close at $4.85 Wednesday. Volume neared 16.2 million shares, or 21.5 times normal trading, as investors fled the stock.
Shares continued south Thursday, losing another 15 percent, and closed flat Friday at $4.12, down a total of 64 percent since the study's release.
ST22 I like this for a bounce play this week.
what are your thoughts??
This is one stock I was definitely looking for a bounce. Huge overreaction. I think NUVO and NEOL will be winners in the next few months too.
Posted by stocktrader22 on :
Okay now in terms of this week/short term...here is what i am keeping a close eye on. And a surfer, I dont like NFLD chart right now. I could be wrong, but i think it may go lower. None of the indicators are peaking up.
Looking at: may buy HOGC at .015, SRCO indicators are go in almost all aspects, TBYH(level II is thin, chart looks pretty decent, but accum must go up for me to buy in, especially since its near overbought levels). FLWE (watch MACD and OBV), FFHL (watching for MOMO), NUVO(chart looks nice),
Posted by BooDog on :
Jav up 5% long term winner here
Posted by stocktrader22 on :
JAV is a heck of a company now up 7%...I think this hits $8 in 6 months or so...good long term hold, Im just not patient enough. Looking to get in if it consolidates, almost at oversold levels, but been going up for months
Posted by a surfer on :
yea JAV is one where waiting doesn't gain you much leverage.
Its a winning co. and your 8 bucks is probably realistic.
Posted by stocktrader22 on :
FLWE is what I'll be paying attention to the most tomorrow. Looks like it may be a nice bottom bouncer back to .10
Posted by roiresearch on :
Posted by BooDog on :
I'm adding STTC to the list. watching it for another squeeeeeeeze
Posted by BooDog on :
not a bad day for sttc. up from .024 to .04 with a close on hod. sad part is it's always short lived. maybe this time it'll show some growth. todays pr... http://biz.yahoo.com/pz/070104/111196.html. Posted by BooDog on :
oops. thread for sttc is in hot stocks - not the micros. lol.
